1. Home
  2. GIS vs JAZZ Comparison

GIS vs JAZZ Comparison

Compare GIS & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo General Mills Inc.

GIS

General Mills Inc.

HOLD

Current Price

$33.89

Market Cap

18.5B

ML Signal

HOLD

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$236.27

Market Cap

15.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GIS
JAZZ
Founded
1866
2003
Country
United States
Ireland
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.5B
15.0B
IPO Year
2003
2007

Fundamental Metrics

Financial Performance
Metric
GIS
JAZZ
Price
$33.89
$236.27
Analyst Decision
Hold
Strong Buy
Analyst Count
16
14
Target Price
$42.07
$217.57
AVG Volume (30 Days)
9.5M
816.4K
Earning Date
03-18-2026
05-05-2026
Dividend Yield
7.08%
N/A
EPS Growth
N/A
N/A
EPS
3.56
4.43
Revenue
$2,037,800,000.00
$1,618,693,000.00
Revenue This Year
N/A
$6.22
Revenue Next Year
N/A
$7.68
P/E Ratio
$9.50
$51.84
Revenue Growth
4.11
N/A
52 Week Low
$31.75
$105.00
52 Week High
$55.13
$243.32

Technical Indicators

Market Signals
Indicator
GIS
JAZZ
Relative Strength Index (RSI) 50.06 58.56
Support Level $32.20 $224.23
Resistance Level $34.49 $243.32
Average True Range (ATR) 0.86 6.98
MACD 0.17 -1.65
Stochastic Oscillator 80.27 60.69

Price Performance

Historical Comparison
GIS
JAZZ

About GIS General Mills Inc.

General Mills is a global packaged-food company that produces snacks, cereal, convenient meals, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Pillsbury, Betty Crocker, Blue Buffalo, and Haagen-Dazs. In fiscal 2025, 81% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. Although most of General Mills' products are sold through retail stores to consumers, the company also sells products to the foodservice channel and the commercial baking industry.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: